endocrinology
Public Health

Shingles vaccine for immunocompromised patients available privately ‘soon’

GlaxoSmithKline is launching its non-live shingles vaccine Shingrix in Australia later this year but expects it will be a “few years” before it is included in the National Immunisation Program. Shingrix was registered by the Therapeutic Goods Administration (TGA) in 2018 for use in adults aged 50 years and older for herpes zoster and postherpetic ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic